Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aslan Pharmaceuticals Ltd ADR (ASLN)

Aslan Pharmaceuticals Ltd ADR (ASLN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 105,235
  • Shares Outstanding, K 37,991
  • Annual Sales, $ 0 K
  • Annual Income, $ -16,200 K
  • 60-Month Beta 2.41
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.32
Trade ASLN with:

Options Overview

Details
  • Implied Volatility 162.23%
  • Historical Volatility 71.86%
  • IV Percentile 50%
  • IV Rank 36.61%
  • IV High 408.29% on 07/08/21
  • IV Low 20.14% on 06/29/21
  • Put/Call Vol Ratio 0.29
  • Today's Volume 9
  • Volume Avg (30-Day) 495
  • Put/Call OI Ratio 0.50
  • Today's Open Interest 3,009
  • Open Int (30-Day) 2,252

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.11
  • Number of Estimates 3
  • High Estimate -0.10
  • Low Estimate -0.11
  • Prior Year -0.10
  • Growth Rate Est. (year over year) -10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.58 +7.36%
on 07/19/21
3.81 -27.30%
on 07/09/21
-0.53 (-16.06%)
since 06/30/21
3-Month
2.50 +10.80%
on 05/13/21
3.87 -28.42%
on 06/14/21
-0.46 (-14.24%)
since 04/30/21
52-Week
1.26 +119.84%
on 09/04/20
6.75 -58.96%
on 03/01/21
+1.17 (+73.13%)
since 07/30/20

Most Recent Stories

More News
3 Biotech Stocks Wall Street Predicts Will Rally by More Than 170%

The rapid spread of the COVID-19 Delta variant is fostering renewed investor interest in the biotech industry. Also, with the increasing demand for treatments for other critical diseases, the industry...

ASLN : 2.77 (-2.12%)
AQST : 3.25 (-5.80%)
ARAV : 4.15 (+0.24%)
Housing Starts, Wholesale Trade Featured in Canada Next Week

Monday U.S. Featured Earnings Simulations Plus, Inc. (NASDAQ: SLP) (Q3) EPS projected for 17 cents, ...

SLP : 47.19 (+0.23%)
ASLN : 2.77 (-2.12%)
JPM : 151.78 (-0.80%)
PEP : 156.95 (+0.09%)
WFC : 45.94 (-1.20%)
GS : 374.88 (-0.71%)
BAC : 38.36 (-0.83%)
C : 67.62 (-1.73%)
BLK : 867.17 (-0.26%)
TSM : 116.64 (+0.42%)
UNH : 412.22 (+0.03%)
MS : 95.98 (-0.31%)
SCHW : 67.95 (-0.90%)
HDB : 70.57 (-0.94%)
ERIC : 11.53 (+0.35%)
ATZ.TO : 36.59 (+0.97%)
TMQ.TO : 2.77 (-1.42%)
Thinking about buying stock in Galectin Therapeutics, Hall of Fame Resort & Entertainment, PubMatic, 360 DigiTech, or Aslan Pharmaceuticals?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GALT, HOFV, PUBM, QFIN, and ASLN.

GALT : 2.75 (+4.96%)
ASLN : 2.77 (-2.12%)
HOFV : 2.96 (+1.72%)
PUBM : 29.71 (-5.47%)
QFIN : 21.25 (-3.32%)
New Strong Sell Stocks for June 8th

ASLN, CANG, ESLT, GCI, and KRYS have been added to the Zacks Rank #5 (Strong Sell) List on June 8, 2021.

GCI : 5.77 (+1.94%)
ESLT : 132.63 (-1.27%)
KRYS : 58.44 (-2.36%)
CANG : 4.37 (+3.07%)
ASLN : 2.77 (-2.12%)
New Strong Sell Stocks for June 4th

ASLN, BLRX, FLXN, ICMB, and MRNS have been added to the Zacks Rank #5 (Strong Sell) List on June 4, 2021.

BLRX : 3.23 (-0.92%)
FLXN : 5.93 (+1.02%)
MRNS : 14.70 (-2.39%)
ASLN : 2.77 (-2.12%)
ICMB : 6.12 (-0.33%)
Bayer's (BAYRY) Q1 Earnings & Revenues Surpass Estimates

Bayer (BAYRY) beat estimates for earnings and revenues for the first quarter of 2021.

JNJ : 172.20 (+0.01%)
BAYRY : 14.8550 (-1.82%)
RGEN : 245.70 (+1.95%)
ASLN : 2.77 (-2.12%)
Kodiak Sciences (KOD) Q1 Earnings Miss, KSI-301 in Focus

Kodiak Sciences (KOD) reports wider-than-expected loss for the first quarter of 2021. Pipeline development remains in focus for the company.

ADPT : 36.66 (+0.14%)
KOD : 83.84 (-4.59%)
ASLN : 2.77 (-2.12%)
MIST : 5.70 (+4.20%)
Catalyst (CPRX) Q1 Earnings Beat Estimates, Revenues Miss

Catalyst's (CPRX) earnings beat estimates in the first quarter of 2021 while revenues missed the same.

ADPT : 36.66 (+0.14%)
CPRX : 5.84 (+0.17%)
ASLN : 2.77 (-2.12%)
MIST : 5.70 (+4.20%)
Epizyme's (EPZM) Q1 Earnings Miss, Revenues Beat Estimates

Epizyme (EPZM) reports wider-than-expected loss in the first quarter of 2021 despite its revenues beating estimates.

RHHBY : 48.2600 (+1.05%)
BMY : 67.87 (-0.41%)
EPZM : 6.63 (-1.92%)
ASLN : 2.77 (-2.12%)
bluebird (BLUE) Q1 Loss Wider Than Expected, Revenues Beat

bluebird (BLUE) reports a wider-than-expected loss for the first quarter of 2021 while revenues beat estimates.

BMY : 67.87 (-0.41%)
BLUE : 25.41 (-0.97%)
NBRV : 1.1000 (-0.90%)
ASLN : 2.77 (-2.12%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

See More Share

Business Summary

ASLAN Pharmaceuticals Limited operates as a clinical-stage biotechnology company. It develops drugs, medicines and novel therapeutics for the treatment of patients with oncology, respiratory and inflammatory diseases. The company's product portfolio includes Varlitinib, ASLAN004, ASLAN002 and ASLAN003...

See More

Key Turning Points

3rd Resistance Point 3.02
2nd Resistance Point 2.96
1st Resistance Point 2.86
Last Price 2.77
1st Support Level 2.70
2nd Support Level 2.64
3rd Support Level 2.54

See More

52-Week High 6.75
Fibonacci 61.8% 4.65
Fibonacci 50% 4.01
Fibonacci 38.2% 3.36
Last Price 2.77
52-Week Low 1.26

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar